Cargando…

Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters

INTRODUCTION: Prior research has demonstrated that personality disorders and clinical psychiatric syndromes are common among users of anabolic–androgenic steroids (AAS). However, the prevalence, expression, and severity of psychopathology differ among AAS users and remain poorly understood. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørstad, Marie Lindvik, Scarth, Morgan, Torgersen, Svenn, Pope, Harrison Graham, Bjørnebekk, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338822/
https://www.ncbi.nlm.nih.gov/pubmed/37150843
http://dx.doi.org/10.1002/brb3.3040
_version_ 1785071710781833216
author Jørstad, Marie Lindvik
Scarth, Morgan
Torgersen, Svenn
Pope, Harrison Graham
Bjørnebekk, Astrid
author_facet Jørstad, Marie Lindvik
Scarth, Morgan
Torgersen, Svenn
Pope, Harrison Graham
Bjørnebekk, Astrid
author_sort Jørstad, Marie Lindvik
collection PubMed
description INTRODUCTION: Prior research has demonstrated that personality disorders and clinical psychiatric syndromes are common among users of anabolic–androgenic steroids (AAS). However, the prevalence, expression, and severity of psychopathology differ among AAS users and remain poorly understood. In this study, we examine the existence of potential clinically coherent psychopathology subgroups, using cluster procedures. METHODS: A sample of 118 male AAS users and 97 weightlifting nonusers was assessed using the Millon Clinical Multiaxial Inventory‐III (MCMI‐III), measuring personality disorders and clinical syndromes. Group differences in MCMI‐III scales were assessed using Wilcoxon‐Mann–Whitney tests and Fisher's exact test. Agglomerative hierarchical clustering was used to identify clusters based on MCMI‐III scale scores from the whole sample. RESULTS: AAS users displayed significantly higher scores on all personality disorder (except narcissistic) and clinical syndrome scales compared to nonusing weightlifters. The clustering analysis found four separate clusters with different levels and patterns of psychopathology. The “no psychopathology” cluster was most common among nonusing weightlifters, while the three other clusters were more common among AAS users: “severe multipathology,” “low multipathology,” and “mild externalizing.” The “severe multipathology” cluster was found almost exclusively among AAS users. AAS users also displayed the highest scores on drug and alcohol dependence syndromes. CONCLUSIONS: AAS users in our sample demonstrated greater psychopathology than the nonusing weightlifters, with many exhibiting multipathology. This may pose a significant challenge to clinical care for AAS users, particularly as there appears to be significant variation in psychopathology in this population. Individual psychiatric profiles should be taken into consideration when providing treatment to this group. SIGNIFICANT OUTCOMES: As a group, AAS users displayed markedly greater psychopathology than nonusing weightlifters. Multipathology was common among AAS users. Four different subgroups of personality profiles were identified with distinct patterns of pathology and severity. LIMITATIONS: The cross‐sectional nature of the study precludes inferences about causality. The study is limited by possible selection bias, as participants choosing to be involved in research may not be entirely representative for the group as a whole. The study is vulnerable to information bias, as the results are based on self‐report measures and interviews.
format Online
Article
Text
id pubmed-10338822
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103388222023-07-14 Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters Jørstad, Marie Lindvik Scarth, Morgan Torgersen, Svenn Pope, Harrison Graham Bjørnebekk, Astrid Brain Behav Original Articles INTRODUCTION: Prior research has demonstrated that personality disorders and clinical psychiatric syndromes are common among users of anabolic–androgenic steroids (AAS). However, the prevalence, expression, and severity of psychopathology differ among AAS users and remain poorly understood. In this study, we examine the existence of potential clinically coherent psychopathology subgroups, using cluster procedures. METHODS: A sample of 118 male AAS users and 97 weightlifting nonusers was assessed using the Millon Clinical Multiaxial Inventory‐III (MCMI‐III), measuring personality disorders and clinical syndromes. Group differences in MCMI‐III scales were assessed using Wilcoxon‐Mann–Whitney tests and Fisher's exact test. Agglomerative hierarchical clustering was used to identify clusters based on MCMI‐III scale scores from the whole sample. RESULTS: AAS users displayed significantly higher scores on all personality disorder (except narcissistic) and clinical syndrome scales compared to nonusing weightlifters. The clustering analysis found four separate clusters with different levels and patterns of psychopathology. The “no psychopathology” cluster was most common among nonusing weightlifters, while the three other clusters were more common among AAS users: “severe multipathology,” “low multipathology,” and “mild externalizing.” The “severe multipathology” cluster was found almost exclusively among AAS users. AAS users also displayed the highest scores on drug and alcohol dependence syndromes. CONCLUSIONS: AAS users in our sample demonstrated greater psychopathology than the nonusing weightlifters, with many exhibiting multipathology. This may pose a significant challenge to clinical care for AAS users, particularly as there appears to be significant variation in psychopathology in this population. Individual psychiatric profiles should be taken into consideration when providing treatment to this group. SIGNIFICANT OUTCOMES: As a group, AAS users displayed markedly greater psychopathology than nonusing weightlifters. Multipathology was common among AAS users. Four different subgroups of personality profiles were identified with distinct patterns of pathology and severity. LIMITATIONS: The cross‐sectional nature of the study precludes inferences about causality. The study is limited by possible selection bias, as participants choosing to be involved in research may not be entirely representative for the group as a whole. The study is vulnerable to information bias, as the results are based on self‐report measures and interviews. John Wiley and Sons Inc. 2023-05-07 /pmc/articles/PMC10338822/ /pubmed/37150843 http://dx.doi.org/10.1002/brb3.3040 Text en © 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Jørstad, Marie Lindvik
Scarth, Morgan
Torgersen, Svenn
Pope, Harrison Graham
Bjørnebekk, Astrid
Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
title Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
title_full Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
title_fullStr Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
title_full_unstemmed Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
title_short Clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
title_sort clustering psychopathology in male anabolic–androgenic steroid users and nonusing weightlifters
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338822/
https://www.ncbi.nlm.nih.gov/pubmed/37150843
http://dx.doi.org/10.1002/brb3.3040
work_keys_str_mv AT jørstadmarielindvik clusteringpsychopathologyinmaleanabolicandrogenicsteroidusersandnonusingweightlifters
AT scarthmorgan clusteringpsychopathologyinmaleanabolicandrogenicsteroidusersandnonusingweightlifters
AT torgersensvenn clusteringpsychopathologyinmaleanabolicandrogenicsteroidusersandnonusingweightlifters
AT popeharrisongraham clusteringpsychopathologyinmaleanabolicandrogenicsteroidusersandnonusingweightlifters
AT bjørnebekkastrid clusteringpsychopathologyinmaleanabolicandrogenicsteroidusersandnonusingweightlifters